USPTO Examiner GILBERT SAMUEL G - Art Unit 3791

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19009968APPLICATOR WITH A RADIATION SOURCE WITHIN A MODULE FOR TREATING TISSUE HAVING ENHANCED VISUALIZATION AND RADIATION SHIELDING CAPABILITIESJanuary 2025March 2025Allow200NoNo
18928125SYSTEMS AND METHODS FOR PROVIDING SEXUAL ENTERTAINMENT BY MONITORING TARGET ELEMENTSOctober 2024June 2025Allow810NoNo
18782067COCK RINGJuly 2024February 2025Allow620NoNo
18644172MASSAGERApril 2024October 2024Allow610NoNo
18591032APPARATUS, SYSTEM AND OPERATION METHOD FOR THE TREATMENT OF MALE SEXUAL DYSFUNCTIONFebruary 2024February 2025Allow1210NoNo
18591244MASSAGERFebruary 2024June 2024Allow410NoNo
18431259Autonomous Insemination in an Intelligent Automated In Vitro Fertilization and Intracytoplasmic Sperm Injection PlatformFebruary 2024March 2025Allow1320YesNo
18545778METHODS AND SYSTEMS FOR SHAPING THE RADIATION DISTRIBUTION PROFILE OF A PROTECTED RADIATION SOURCE USED FOR TREATING MEDICAL CONDITIONSDecember 2023September 2024Allow900YesNo
18545897AESTHETIC METHOD OF BIOLOGICAL STRUCTURE TREATMENT BY MAGNETIC FIELDDecember 2023November 2024Allow1120YesNo
18530703METHOD AND APPARATUS FOR FIXATION OF IMPLANTABLE DEVICE FOR URINARY CONTINENCEDecember 2023June 2025Allow1810NoNo
18523055PUMP ASSEMBLY FOR A PENILE PROSTHESISNovember 2023June 2025Allow1910NoNo
18504719SYSTEMS, METHODS, AND DEVICES FOR ALLEVIATING ERECTILE DYSFUNCTIONNovember 2023February 2025Abandon1610NoNo
18500169Radiotherapy Template AssemblyNovember 2023June 2025Allow1920YesNo
18483768SYSTEMS AND METHODS FOR INCONTINENCE CONTROLOctober 2023February 2025Abandon1710NoNo
18377890COMPOSITIONS FOR REMODELING EXTRACELLULAR MATRIX AND METHODS OF USE THEREOFOctober 2023March 2025Allow1710NoNo
18454340Lighting DeviceAugust 2023September 2024Allow1210YesNo
18263716Radiotherapy ApplicatorAugust 2023March 2024Allow710NoNo
18352114DEVICE FOR CONTROLLING FECAL INCONTINENCEJuly 2023August 2024Allow1410NoNo
18346819APPLICATOR WITH A RADIATION SOURCE WITHIN A MODULE FOR TREATING TISSUE HAVING ENHANCED VISUALIZATION AND RADIATION SHIELDING CAPABILITIESJuly 2023September 2024Allow1510YesNo
18208777SYSTEM, METHOD, AND NON-TRANSITORY STORAGE MEDIUM FOR PROVIDING ONLINE ENTERTAINMENT IN ASSOCIATION WITH AN INTERACTIVE ADULT TOYJune 2023September 2024Allow1510NoNo
18206783MAGNETICALLY-ASSISTED DELIVERY INTO AND THROUGH THE SKINJune 2023September 2024Abandon1610NoNo
18325402MAGNETIC BIO-THERAPY DEVICE AND METHODMay 2023September 2024Allow1510YesNo
18037207MEDICAL DEVICE FOR PREVENTING REFLUX IN THE CERVIXMay 2023October 2024Allow1820NoNo
18316694PROJECTION MAPPING OF RADIATION SUITESMay 2023September 2024Allow1610NoNo
18309938PUMP BULB WITH CONTROL FEATURESMay 2023March 2025Allow2330YesNo
18194122MULTIMODAL THERAPY FOR CANCER CELL DESTRUCTIONMarch 2023September 2024Abandon1720NoNo
18182663AESTHETIC METHOD OF BIOLOGICAL STRUCTURE TREATMENT BY MAGNETIC FIELDMarch 2023May 2024Allow1420YesNo
18119871PENILE PROSTHETIC AND A PLATE ADAPTED TO ORIENT THE PENILE PROSTHETIC IN AN ANATOMICALLY NATAL PENIS POSITION THAT IS ADAPTED FOR PENETRATIVE INTERCOURSEMarch 2023March 2024Allow1320NoNo
18110807EXTERNAL HYDRAULICALLY ERECTABLE PHALLUS PROSTHETIC DEVICEFebruary 2023June 2023Allow410NoNo
18165916Method And Apparatus For Oncomagnetic TreatmentFebruary 2023June 2025Allow2830YesNo
18095451TRANSDERMALLY POWERED MR-CONDITIONAL MEDICAL IMPLANT INFLATOR SYSTEMJanuary 2023December 2023Allow1110YesNo
18069810AESTHETIC METHOD OF BIOLOGICAL STRUCTURE TREATMENT BY MAGNETIC FIELDDecember 2022September 2023Allow910YesNo
18002321MAGNETIC BIO-THERAPY DEVICE AND METHODDecember 2022May 2023Allow510NoNo
17925838Radiotherapy Template AssemblyNovember 2022September 2023Allow1010YesNo
17988420FINGER-SPLINTING SHEATH DEVICE & METHODNovember 2022July 2023Allow810NoNo
17985444SYSTEMS AND METHODS FOR DETERMINING A TRAJECTORY FOR A BRAIN STIMULATION LEADNovember 2022May 2024Abandon1810NoNo
17978824APPLICATOR WITH A RADIATION SOURCE WITHIN A MODULE FOR TREATING TISSUE HAVING ENHANCED VISUALIZATION AND RADIATION SHIELDING CAPABILITIESNovember 2022June 2023Allow710NoNo
17971374SYSTEM AND METHOD FOR INTRAUTERINE INSEMINATIONOctober 2022September 2023Allow1110NoNo
17969131COMPOSITIONS AND METHODS FOR ENHANCING THE BIOLOGICAL RESPONSE TO CHEMICAL AGENTS AND PHYSICAL STIMULIOctober 2022October 2023Allow1220NoNo
18047070ENDORECTAL PROBE DEVICE FOR EFFECTING RADIATION TREATMENT OF COLORECTAL CANCEROUS TISSUE IN THE RECTUM OF A HUMAN OR ANIMAL SUBJECTOctober 2022February 2024Allow1610NoNo
17941985HYPERTHERMIA BRACHYTHERAPY DEVICE AND METHOD FOR TREATING TUMORSSeptember 2022March 2023Allow610YesNo
17823248INTERNAL BODY CAVITY THERAPEUTIC APPLICATORS AND METHODS FOR USING THEMAugust 2022November 2023Allow1520YesNo
17895367INTRAVAGINAL CONCEPTION ASSISTANCE DEVICE, KIT OF PARTS, AND METHOD FOR INCREASING THE CHANCES OF GETTING PREGNANTAugust 2022June 2024Allow2220NoNo
17892303COMBINED PULSED ELECTROMAGNETIC FIELD AND LOW INTENSITY SHOCKWAVE SYSTEM AND METHODAugust 2022January 2023Allow400NoNo
17877770SYSTEM, METHOD, AND NON-TRANSITORY STORAGE MEDIUM FOR PROVIDING ONLINE ENTERTAINMENT IN ASSOCIATION WITH AN INTERACTIVE ADULT TOYJuly 2022March 2023Allow700NoNo
17859005COMPOSITIONS FOR REMODELING EXTRACELLULAR MATRIX AND METHODS OF USE THEREOFJuly 2022June 2023Allow1110NoNo
17837075KIT OF PARTS PROVIDING COMPONENTS IMPLANTABLE IN A PATIENT TO ADAPT A NEOPENIS OF THE PATIENT FOR PENETRATIVE INTERCOURSEJune 2022December 2022Allow600NoNo
17752294AESTHETIC METHOD OF BIOLOGICAL STRUCTURE TREATMENT BY MAGNETIC FIELDMay 2022March 2023Allow1030NoNo
17752261AESTHETIC METHOD OF BIOLOGICAL STRUCTURE TREATMENT BY MAGNETIC FIELDMay 2022December 2022Allow610NoNo
17728845SYSTEMS AND METHODS FOR MANAGING SLEEP DISORDERSApril 2022April 2023Abandon1110NoNo
17704973SEXUAL STIMULATION DEVICEMarch 2022March 2023Allow1110YesNo
17675798AESTHETIC METHOD OF BIOLOGICAL STRUCTURE TREATMENT BY MAGNETIC FIELDFebruary 2022September 2022Allow710NoNo
17666581PUMP HAVING A VOLUME AMPLIFICATION MECHANISM FOR AN INFLATABLE PENILE PROSTHESISFebruary 2022March 2024Allow2500YesNo
17567101METHOD AND APPARATUS FOR ONCOMAGNETIC TREATMENTDecember 2021October 2022Allow910YesNo
17645176PUMP BULB WITH CONTROL FEATURESDecember 2021January 2023Allow1310NoNo
17644124UNIVERSALLY FRIENDLY OBTURATOR (UFO) FOR BRACHYTHERAPY TREATMENT OF CERVICAL CANCERDecember 2021March 2025Allow3930YesNo
17617529RADIATION SHIELDS FOR BRACHYTHERAPYDecember 2021February 2025Allow3830NoNo
17532006PENILE PROSTHESIS IMPLANTATION SYSTEMNovember 2021December 2023Allow2510YesNo
17610128SYSTEMS, METHODS, AND DEVICES FOR ALLEVIATING ERECTILE DYSFUNCTIONNovember 2021August 2023Allow2110NoNo
17516869SYSTEM AND METHOD FOR A DIGITALLY-INTERACTIVE PLUSH BODY THERAPEUTIC APPARATUSNovember 2021April 2023Allow1710NoNo
17505601METHODS AND SYSTEMS FOR SHAPING THE RADIATION DISTRIBUTION PROFILE OF A PROTECTED RADIATION SOURCE USED FOR TREATING MEDICAL CONDITIONSOctober 2021August 2023Allow2210YesNo
17503173ADULT TOY WITH TRANSPARENT OUTER BODYOctober 2021December 2024Allow3820YesNo
17450779PUMP ASSEMBLY FOR A PENILE PROSTHESISOctober 2021May 2024Allow3121NoNo
17497877SUCTION DEVICES FOR PROVIDING SEXUAL PLEASUREOctober 2021June 2025Allow4400YesNo
17449851INFLATABLE MEDICAL IMPLANT HAVING A PRESSURE MONITOROctober 2021February 2025Allow4110YesNo
17491875THERAPEUTIC DEVICE FOR ALLEVIATING A SEXUAL DYSFUNCTION AND METHOD OF MAKING THE SAMEOctober 2021December 2024Allow3840YesNo
17593760MODULAR BRACHYTHERAPY APPLICATORSeptember 2021January 2024Allow2820YesNo
17440201Water And Gas Dual-Purpose Electric Erection AidSeptember 2021February 2024Allow2920NoNo
17440375ROTATING SHIELD BRACHYTHERAPY APPARATUS AND METHODSeptember 2021January 2025Allow4010NoNo
17471874MALE MASTURBATION DEVICESeptember 2021March 2025Abandon4210NoNo
17447112MULTIPLE PUMP SYSTEM FOR INFLATABLE PENILE PROSTHESISSeptember 2021January 2025Allow4020NoNo
17460366IMPLANTABLE URETHRA RESTRICTION DEVICEAugust 2021March 2025Allow4311NoNo
17434924PROSTHETIC SYSTEM WITH MOTORIZED HYDRAULIC PUMP DESIGNED TO CONTROL THE INFLATION OF AN INFLATABLE ELEMENTAugust 2021August 2024Allow3610NoNo
17401234MALE MASTURBATING APPARATUSAugust 2021August 2024Allow3710NoNo
17428035RE-ACTIVATABLE RADIATION SOURCE FOR BRACHYTHERAPYAugust 2021June 2025Abandon4620NoNo
17381167Erectile Dysfunction Treatment System and MethodJuly 2021October 2023Allow2710NoNo
17379350MALE MASTURBATING DEVICEJuly 2021March 2025Allow4420NoNo
17367006TRANSDERMALLY POWERED MR-CONDITIONAL MEDICAL IMPLANT INFLATOR SYSTEMJuly 2021September 2022Allow1500YesNo
17305103MULTIMODAL THERAPY FOR CANCER CELL DESTRUCTIONJune 2021January 2023Allow1910NoNo
17305080Penile straightening devicesJune 2021September 2023Abandon2610YesNo
17355513STIMULATION DEVICES AND METHODS OF USEJune 2021February 2024Allow3210NoNo
17354112COMPOSITIONS AND METHODS FOR ENHANCING THE BIOLOGICAL RESPONSE TO CHEMICAL AGENTS AND PHYSICAL STIMULIJune 2021January 2023Abandon1910NoNo
17348241PENILE SLEEVE DEVICES AND PENILE STOCKING INSERT AND METHODS OF MAKING THE SAMEJune 2021August 2022Allow1410NoNo
17345168SEXUAL AID DEVICE FOR SIMULATING THE FORCE-RESPONSE CHARACTERISTICS OF AN ERECT PENISJune 2021March 2025Abandon4510NoNo
17343786Activity levels for diffusing alpha-emitter radiation therapyJune 2021April 2023Abandon2210NoNo
17312479ACCELERATION PROTECTION TROUSERSJune 2021August 2022Allow1410YesNo
17343784Diffusing alpha-emitter radiation therapy for breast and prostate cancerJune 2021March 2023Abandon2110NoNo
17343779Diffusing alpha-emitter radiation therapy for pancreatic cancerJune 2021March 2023Abandon2110NoNo
17343781Diffusing alpha-emitter radiation therapy for squamous cell carcinomaJune 2021March 2023Abandon2110NoNo
17343773Diffusing alpha-emitter radiation therapy for colon cancerJune 2021March 2023Abandon2110NoNo
17343783Diffusing alpha-emitter radiation therapy for glioblastomaJune 2021March 2023Abandon2110NoNo
17343789Diffusing alpha-emitter radiation therapy for melanomaJune 2021March 2023Abandon2110NoNo
17303816Inflatable Penile Prosthesis CylindersJune 2021November 2023Allow3020NoNo
17331843IMPLANTABLE MIDDLE EAR TRANSDUCER HAVING DIAGNOSTIC DETECTION SENSORMay 2021November 2022Allow1810YesNo
17297384FOLLICULAR FLUID ASPIRATIONMay 2021February 2025Allow4510NoNo
17303260COLLAPSIBLE ISOLATION SYSTEM AND METHOD OF USEMay 2021December 2024Abandon4310NoNo
17326947Generating Multi-Sensory Media Channels from a Base Digital Waveform for Delivery in a Vibroacoustic Therapy BedMay 2021March 2025Allow4610NoNo
17294811PHOTOBIOMODULATION THERAPY TO IMPROVE FUNCTIONAL MOBILITY OF STROKE SURVIVORSMay 2021January 2025Allow4411NoNo
17320607CHAIN MAIL SURGICAL COLLAR AND METHOD OF PERCUTANEOUS DEVICE STABILIZATION THEREWITHMay 2021August 2024Allow3910NoNo
17318356DEVICE FOR SHIELDING IMPLANTABLE RADIOACTIVE SOURCES TO ACHIEVE DIRECTIONAL DOSINGMay 2021March 2023Abandon2220NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GILBERT, SAMUEL G.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
2
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
19.4%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
15
Allowed After Appeal Filing
3
(20.0%)
Not Allowed After Appeal Filing
12
(80.0%)
Filing Benefit Percentile
23.4%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner GILBERT, SAMUEL G - Prosecution Strategy Guide

Executive Summary

Examiner GILBERT, SAMUEL G works in Art Unit 3791 and has examined 521 patent applications in our dataset. With an allowance rate of 82.3%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 30 months.

Allowance Patterns

Examiner GILBERT, SAMUEL G's allowance rate of 82.3% places them in the 48% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by GILBERT, SAMUEL G receive 1.68 office actions before reaching final disposition. This places the examiner in the 47% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by GILBERT, SAMUEL G is 30 months. This places the examiner in the 44% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +13.2% benefit to allowance rate for applications examined by GILBERT, SAMUEL G. This interview benefit is in the 54% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 31.8% of applications are subsequently allowed. This success rate is in the 58% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 57.4% of cases where such amendments are filed. This entry rate is in the 80% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 84.6% of appeals filed. This is in the 75% percentile among all examiners. Of these withdrawals, 54.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 56.4% are granted (fully or in part). This grant rate is in the 71% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 6.3% of allowed cases (in the 92% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.3% of allowed cases (in the 67% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.